Tandi E Matsha, Shanel Raghubeer, Abegail M Tshivhase, Saarah F G Davids, Gloudina M Hon, Lise Bjørkhaug, Rajiv T Erasmus
{"title":"Incidence of <i>HNF1A</i> and <i>GCK</i> MODY Variants in a South African Population.","authors":"Tandi E Matsha, Shanel Raghubeer, Abegail M Tshivhase, Saarah F G Davids, Gloudina M Hon, Lise Bjørkhaug, Rajiv T Erasmus","doi":"10.2147/TACG.S281872","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aim: </strong>Maturity-onset diabetes of the young (MODY) is the result of single gene variants. To date, fourteen different MODY subtypes have been described. Variants in genes coding for glucokinase (<i>GCK</i>, MODY2) and hepatic nuclear factor 1 alpha (<i>HNF1A</i>, MODY3) are most frequently encountered. MODY patients are often misdiagnosed with type 1 or type 2 diabetes, resulting in incorrect treatment protocols. At the time of reporting, no data are available on MODY prevalence in populations from Africa. Our study aimed to investigate and report on the incidence of MODY-related variants, specifically <i>HNF1A</i> variants, in a population from the Western Cape.</p><p><strong>Methods: </strong>Study participants were recruited (1643 in total, 407 males, 1236 females) and underwent anthropometric tests. Thereafter, blood was collected, and real-time PCR was used to screen for specific variants in <i>HNF1A</i> and <i>GCK</i> genes.</p><p><strong>Results: </strong>Ninety-seven individuals (5.9%) were identified with a specific <i>HNF1A</i> gene polymorphism (rs1169288) and twelve (0.9%) with a <i>GCK</i> polymorphism (rs4607517).</p><p><strong>Conclusion: </strong>In total, 6.6% of the study population expressed MODY variants. To our knowledge, we are the first to report on MODY incidence in Africa. This research provides the basis for MODY incidence studies in South Africa, as well as data on non-Caucasian populations.</p>","PeriodicalId":39131,"journal":{"name":"Application of Clinical Genetics","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2020-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ab/74/tacg-13-209.PMC7754620.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Application of Clinical Genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/TACG.S281872","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and aim: Maturity-onset diabetes of the young (MODY) is the result of single gene variants. To date, fourteen different MODY subtypes have been described. Variants in genes coding for glucokinase (GCK, MODY2) and hepatic nuclear factor 1 alpha (HNF1A, MODY3) are most frequently encountered. MODY patients are often misdiagnosed with type 1 or type 2 diabetes, resulting in incorrect treatment protocols. At the time of reporting, no data are available on MODY prevalence in populations from Africa. Our study aimed to investigate and report on the incidence of MODY-related variants, specifically HNF1A variants, in a population from the Western Cape.
Methods: Study participants were recruited (1643 in total, 407 males, 1236 females) and underwent anthropometric tests. Thereafter, blood was collected, and real-time PCR was used to screen for specific variants in HNF1A and GCK genes.
Results: Ninety-seven individuals (5.9%) were identified with a specific HNF1A gene polymorphism (rs1169288) and twelve (0.9%) with a GCK polymorphism (rs4607517).
Conclusion: In total, 6.6% of the study population expressed MODY variants. To our knowledge, we are the first to report on MODY incidence in Africa. This research provides the basis for MODY incidence studies in South Africa, as well as data on non-Caucasian populations.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
